Sarepta Financial News
23.06 / 22:43
16.02 / 13:03
Target
CEO
Food
Trade
President
Sarepta
patient
Sarepta stock jumps on FDA nod for ELEVIDYS gene therapy
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has seen its stock price surge by more than 11% in premarket trading after the U.S. Food and Drug Administration (FDA) accepted and filed its Efficacy Supplement application to the Biologics License Application (BLA) for ELEVIDYS.
07.01 / 21:29
markets
Career
CEO
President
Sarepta
information
reports
Calliditas names Maria Törnsén President North America
STOCKHOLM — Calliditas Therapeutics AB (NASDAQ:CALT) (Nasdaq Stockholm: CALTX), a biopharmaceutical company specializing in rare diseases, today announced the appointment of Maria Törnsén as President of its North American operations. Törnsén, who brings over two decades of experience in the biopharma sector, will oversee all U.S. operations and report directly to the CEO, Renée Aguiar-Lucander.
11.11 / 16:13
Target
Reuters
Mobile
Sarepta
Inside
reports
Weekly
stake
BioMarin gains on report Elliott has a stake: Insider trades & hedge funds weekly
Investing.com — Here is your Pro Recap of the biggest insider trades and institutional investor headlines you may have missed this week: Elliott takes a stake in Biomarin Pharmaceutical, Vincent McMahon to sell 8.4 million TKO shares, and top brass buys at Exxon Mobil , Amphenol, Air Products and Chemicals, and Sarepta Therapeutics.
20.08 / 14:29
SEC
CEO
Strategy
Lennar
Sarepta
Inside
exclusive
Weekly
Buffett goes big on homebuilders: Insider trades & hedge funds weekly
Investing.com — Here is your Pro Recap of the biggest insider trades and institutional investor headlines you may have missed last week: news out of Starboard Value LP and Bloomin Brands, Berkshire Hathaway and DR Horton, Lennar , and NVR, and top brass purchases at Forward Air, TG Therapeutics, Amarin , Funko, and Sarepta Therapeutics.
17.08 / 19:39
UPS
Progressive
Manufacturing
Sarepta
pricing
Government in talks with companies over pricing of rare diseases drugs
drugs used for treatment of rare diseases with pharmaceutical companies including Sanofi, Sarepta and Roche to bring relief to patients who are unable get treatment due to exorbitant prices of drugs. «Discussions relating to pricing and supplies of medicines with various pharma companies are underway,» the government has informed the Delhi High Court that has been hearing a batch of petitions filed by rare disease patients and their caretakers.
11.07 / 15:33
UPS
Aware
Biogen
Sarepta
FDA’s OK Isn’t Always a Happy Day for Biotech Investors
Biotech companies often spend years—and millions of dollars—to develop a drug they hope will make it to market. If the day comes when their medicine finally gets regulatory approval, it is usually a cause for celebration by management and employees. Investors should curb their enthusiasm.
04.04 / 13:29
01.03 / 22:49
frequently asked questions about Sarepta
What is Sarepta and why is it relevant?
Sarepta is a significant category that interests a wide audience. On our site, we regularly publish news related to this subject.
Where can I find the latest updates on Sarepta?
All recent news about Sarepta can be found in the highlighted block. We publish information as it becomes available.
How can I verify the accuracy of information on Sarepta?
We rely on trusted sources to ensure that the information about Sarepta is accurate and helpful for our readers.